摘要 |
<p>The invention provides methods for treating ocular diseases using a recombinant vehicle to express a protein useful in the treatment of ocular disease, with particular preference for use of neurotrophin-4 (NT4) for targeting subpopulations of cells in the retina. A genetically engineered gene transfer vector containing sequences encoding a growth factor such as neurotrophin-4 (NT4) is used to transduce cells of the retinal ganglion cell (RGC) layer, in situ, via administration of the vector intravitreally. Accordingly, methods are disclosed for treating subjects in need thereof by therapeutic protein delivery via a recombinant expression vector, including rescue of photoreceptors by targeting the RGC layer subpopulation of retinal cells.</p> |
申请人 |
CEREGENE, INC.;BARTUS, RAYMOND, T.;BISHOP, KATHIE, M.;GASMI, MEHDI |
发明人 |
BARTUS, RAYMOND, T.;BISHOP, KATHIE, M.;GASMI, MEHDI |